Thu, August 4, 2022
Wed, August 3, 2022
Tue, August 2, 2022
Mon, August 1, 2022
Sun, July 31, 2022
Fri, July 29, 2022

Nathan Rich Maintained (TEVA) at Hold with Increased Target to $10 on, Aug 2nd, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-increased-target-to-10-on-aug-2nd-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Nathan Rich of Goldman Sachs, Maintained "Teva Pharmaceutical Industries Limited" (TEVA) at Hold with Increased Target from $9 to $10 on, Aug 2nd, 2022.

Nathan has made no other calls on TEVA in the last 4 months.



There are 4 other peers that have a rating on TEVA. Out of the 4 peers that are also analyzing TEVA, 2 agree with Nathan's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Ashwani Verma of "UBS" Initiated at Hold and Held Target at $10 on, Tuesday, June 14th, 2022
  • Jason Gerberry of "B of A Securities" Upgraded from Sell to Hold and Held Target at $9 on, Tuesday, May 17th, 2022


These are the ratings of the 2 analyists that currently disagree with Nathan


  • David Amsellem of "Piper Sandler" Downgraded from Hold to Sell and Decreased Target to $7 on, Wednesday, May 4th, 2022
  • Balaji Prasad of "Barclays" Upgraded from Hold to Buy and Increased Target to $13 on, Tuesday, April 5th, 2022

Publication Contributing Sources